IP Library Granted Patent US 8,808,280
Granted Patent B2
US 8,808,280 · App. 13/452,664 · Granted Aug 19, 2014

Systems, assemblies, and methods for treating a bronchial tree

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,808,280
App. No.
13/452,664
Granted
Aug 19, 2014
Kind
B2
Abstract

Systems, assemblies, and methods to treat pulmonary diseases are used to decrease nervous system input to distal regions of the bronchial tree within the lungs. Treatment systems damage nerve tissue to temporarily or permanently decrease nervous system input. The treatment systems are capable of heating nerve tissue, cooling the nerve tissue, delivering a flowable substance that cause trauma to the nerve tissue, puncturing the nerve tissue, tearing the nerve tissue, cutting the nerve tissue, applying pressure to the nerve tissue, applying ultrasound to the nerve tissue, applying ionizing radiation to the nerve tissue, disrupting cell membranes of nerve tissue with electrical energy, or delivering long acting nerve blocking chemicals to the nerve tissue.

Claims (23)

1. A method of treating a subject comprising:

delivering energy so as to damage a nerve trunk extending along an exterior surface of a wall of a first airway of the subject such that airway resistance in a second airway distal to the first airway is reduced.

2. The method of claim 1 wherein the nerve trunk is disposed within connective tissue surrounding the wall of the first airway.

3. The method of claim 1 wherein the nerve trunk is damaged using a treatment device positioned in the first airway, the method further comprising inhibiting damage to airway tissue disposed radially between the treatment device and the nerve trunk.

4. The method of claim 3 wherein the inhibiting damage step comprises cooling the airway tissue using the treatment device.

5. The method of claim 4 wherein the cooling step comprises absorbing heat from the airway tissue with a cooling element on the treatment device.

6. The method of claim 4 wherein the treatment device comprises an energy emitter for delivering energy to the nerve trunk.

7. The method of claim 1 wherein the nerve trunk is damaged by delivering energy from a treatment device in the first airway, and wherein the airway resistance in the second airway is reduced without delivering energy in the second airway.

8. The method of claim 1 wherein the first airway is between a trachea and a lung of the subject.

9. The method of claim 8 wherein the first airway comprises a left or right main bronchus or a bronchus intermedius.

10. The method of claim 1 wherein the first airway is a first generation airway located outside of the left and right lungs.

11. A method of treating a subject comprising:

delivering energy from a treatment device in a first airway of the subject to damage nerve tissue along the first airway sufficiently to reduce airway resistance in a second airway distal to the first airway without delivering energy from the treatment device in the second airway.

12. The method of claim 11 wherein the nerve tissue is closer to an exterior surface of a wall of the first airway than to an interior surface of the wall of the first airway.

13. The method of claim 11 wherein the nerve tissue is disposed along an exterior surface of a wall of the first airway.

14. The method of claim 11 wherein the nerve tissue is radially outside a smooth muscle layer of the first airway.

15. The method of claim 11 further comprising inhibiting damage to airway tissue disposed radially between the treatment device and the nerve tissue.

16. The method of claim 15 wherein the inhibiting damage step comprises cooling the airway tissue using the treatment device.

17. The method of claim 16 wherein the cooling step comprises absorbing heat from the airway tissue with a cooling element on the treatment device.

18. The method of claim 16 wherein the treatment device comprises an energy emitter for delivering energy to the nerve tissue.

19. The method of claim 11 wherein the first airway is between a trachea and a lung of the subject.

20. The method of claim 19 wherein the first airway comprises a left or right main bronchus or a bronchus intermedius.

21. The method of claim 11 wherein the first airway is a first generation airway located outside of the left and right lungs.

Assignments (5)
SECURITY INTEREST Recorded Oct 16, 2024
From: NUVAIRA, INC.
To: INNOVATUS LIFE SCIENCES LENDING FUND 1, LP
Reel/Frame 069175/0918 →
SECURITY INTEREST Recorded Dec 21, 2021
From: NUVAIRA, INC.
To: INNOVATUS LIFE SCIENCES LENDING FUND 1, LP
Reel/Frame 058561/0979 →
CHANGE OF NAME Recorded Jun 20, 2017
From: HOLAIRA, INC.
To: NUVAIRA, INC.
Reel/Frame 042915/0068 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 8, 2013
From: MAYSE, MARTIN L.; DIMMER, STEVEN C.
To: INNOVATIVE PULMONARY SOLUTIONS, INC.
Reel/Frame 031362/0487 →
CHANGE OF NAME Recorded Feb 6, 2013
From: INNOVATIVE PULMONARY SOLUTIONS, INC.
To: HOLAIRA, INC.
Reel/Frame 029768/0930 →